REWIND: HbA1c reduction in dulaglutide-treated patients irrespective of duration of diabetes, microvascular disease and BMI – a post-hoc analysis
- Homepage
- >
- Publications
- >
- REWIND: HbA1c reduction in dulaglutide-treated patients irrespective of duration of diabetes, microvascular disease and BMI – a post-hoc analysis
